这是一篇来自已证抗体库的有关人类 Noxa的综述，是根据21篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Noxa 抗体。
Noxa 同义词: APR; NOXA

Enzo Life Sciences
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 1:500; 图 4a
Enzo Life Sciences Noxa抗体（Alexis Biochemicals, ALX-804-408)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4a). elife (2019) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 图 1
Enzo Life Sciences Noxa抗体（Enzo Life Sciences, ALX-804-408)被用于被用于免疫印迹在人类样本上 (图 1). Oncotarget (2016) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 图 2
Enzo Life Sciences Noxa抗体（Enzo, ALX-804-408)被用于被用于免疫印迹在人类样本上 (图 2). Cell Death Dis (2016) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 1:1000; 图 8
Enzo Life Sciences Noxa抗体（Enzo, ALX-804-408-C100)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8). Oncotarget (2015) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类
Enzo Life Sciences Noxa抗体（Enzo, 114C307.1)被用于被用于免疫印迹在人类样本上. Cell Death Dis (2014) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 1:1000
Enzo Life Sciences Noxa抗体（Alexis Biochemicals, 114C307.1)被用于被用于免疫印迹在人类样本上浓度为1:1000. Hepatol Res (2010) ncbi
赛默飞世尔
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 图 2c
赛默飞世尔 Noxa抗体（Thermo Fisher, 114C307.1)被用于被用于免疫印迹在人类样本上 (图 2c). Biochem Biophys Res Commun (2017) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 图 1b
赛默飞世尔 Noxa抗体（Thermo Fisher, 114C307.1)被用于被用于免疫印迹在人类样本上 (图 1b). Oncotarget (2016) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 图 1a
赛默飞世尔 Noxa抗体（Thermo Fisher, 114C307.1)被用于被用于免疫印迹在人类样本上 (图 1a). Biochem Biophys Res Commun (2016) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 图 1
赛默飞世尔 Noxa抗体（Thermo Fisher, 114C307.1)被用于被用于免疫印迹在人类样本上 (图 1). Cancer Biol Ther (2016) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类
赛默飞世尔 Noxa抗体（Thermo Fisher Scientific, 114C307.1)被用于被用于免疫印迹在人类样本上. Cell Death Dis (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆（114C307）
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Noxa抗体（Santa Cruz, sc-56169)被用于被用于免疫印迹在人类样本上 (图 4). PLoS ONE (2016) ncbi
小鼠 单克隆（114C307）
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 Noxa抗体（Santa Cruz, sc-56169)被用于被用于免疫印迹在人类样本上 (图 3). Genes Dev (2016) ncbi
小鼠 单克隆（114C307）
  • 免疫印迹; 人类; 1:500; 表 1
圣克鲁斯生物技术 Noxa抗体（Santa Cruz, sc-56169)被用于被用于免疫印迹在人类样本上浓度为1:500 (表 1). Methods Mol Biol (2015) ncbi
Novus Biologicals
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 图 st2
Novus Biologicals Noxa抗体（Imgenex, 114C307.1)被用于被用于免疫印迹在人类样本上 (图 st2). Oncotarget (2015) ncbi
小鼠 单克隆（114C307.1）
  • 免疫印迹; 人类; 图 4
Novus Biologicals Noxa抗体（Imgenex, 114C307.1)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2015) ncbi
默克密理博中国
小鼠 单克隆
  • 免疫印迹; 人类; 图 s3
默克密理博中国 Noxa抗体（Millipore, OP180)被用于被用于免疫印迹在人类样本上 (图 s3). Antioxid Redox Signal (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:200; 图 s6d
默克密理博中国 Noxa抗体（Calbiochem, OP180)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 s6d). Nat Cell Biol (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 2
默克密理博中国 Noxa抗体（Calbiochem, OP180)被用于被用于免疫印迹在人类样本上 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆
  • 免疫印迹; 小鼠; 图 9a
默克密理博中国 Noxa抗体（EMD Millipore, OP180)被用于被用于免疫印迹在小鼠样本上 (图 9a). J Cell Biol (2015) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 7
默克密理博中国 Noxa抗体（EMD化学品, OP180)被用于被用于免疫印迹在人类样本上 (图 7). J Biol Chem (2015) ncbi
文章列表
  1. Hagenbuchner J, Obsilova V, Kaserer T, Kaiser N, Rass B, Psenakova K, et al. Modulating FOXO3 transcriptional activity by small, DBD-binding molecules. elife. 2019;8: pubmed 出版商
  2. Suzuki J, Nakajima W, Suzuki H, Asano Y, Tanaka N. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1. Biochem Biophys Res Commun. 2017;482:1334-1340 pubmed 出版商
  3. Seo B, Min K, Woo S, Choe M, Choi K, Lee Y, et al. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP. Antioxid Redox Signal. 2017;27:215-233 pubmed 出版商
  4. Twardziok M, Kleinsimon S, Rolff J, Jäger S, Eggert A, Seifert G, et al. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma. PLoS ONE. 2016;11:e0159749 pubmed 出版商
  5. Walerych D, Lisek K, Sommaggio R, Piazza S, Ciani Y, Dalla E, et al. Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. Nat Cell Biol. 2016;18:897-909 pubmed 出版商
  6. Nakajima W, Sharma K, Lee J, Maxim N, Hicks M, Vu T, et al. DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa/MCL-1/CDK2 complex. Oncotarget. 2016;7:36353-36365 pubmed 出版商
  7. O Neill K, Huang K, Zhang J, Chen Y, Luo X. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane. Genes Dev. 2016;30:973-88 pubmed 出版商
  8. Matsumoto M, Nakajima W, Seike M, Gemma A, Tanaka N. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells. Biochem Biophys Res Commun. 2016;473:490-6 pubmed 出版商
  9. Gilormini M, Malesys C, Armandy E, Manas P, Guy J, Magne N, et al. Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC. Oncotarget. 2016;7:16731-44 pubmed 出版商
  10. Le Pen J, Maillet L, Sarosiek K, Vuillier C, Gautier F, Montessuit S, et al. Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL. Cell Death Dis. 2016;7:e2083 pubmed 出版商
  11. Nakajima W, Sharma K, Hicks M, Le N, Brown R, Krystal G, et al. Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer. Cancer Biol Ther. 2016;17:27-35 pubmed 出版商
  12. Lauková J, Kozubík A, Hofmanová J, Nekvindová J, Sova P, Moyer M, et al. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. PLoS ONE. 2015;10:e0141020 pubmed 出版商
  13. Vétillard A, Jonchère B, Moreau M, Toutain B, Henry C, Fontanel S, et al. Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis. Oncotarget. 2015;6:43342-62 pubmed 出版商
  14. Tiffen J, Gunatilake D, Gallagher S, Gowrishankar K, Heinemann A, Cullinane C, et al. Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes. Oncotarget. 2015;6:27023-36 pubmed 出版商
  15. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  16. Xie C, Wei D, Zhao L, Marchetto S, Mei L, Borg J, et al. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis. J Cell Biol. 2015;209:721-37 pubmed 出版商
  17. Davis A, Qiao S, Lesson J, Rojo de la Vega M, Park S, Seanez C, et al. The quinone methide aurin is a heat shock response inducer that causes proteotoxic stress and Noxa-dependent apoptosis in malignant melanoma cells. J Biol Chem. 2015;290:1623-38 pubmed 出版商
  18. Roufayel R, Johnston D, Mosser D. The elimination of miR-23a in heat-stressed cells promotes NOXA-induced cell death and is prevented by HSP70. Cell Death Dis. 2014;5:e1546 pubmed 出版商
  19. Vega Naredo I, Cunha Oliveira T, Serafim T, Sardao V, Oliveira P. Analysis of pro-apoptotic protein trafficking to and from mitochondria. Methods Mol Biol. 2015;1241:163-80 pubmed 出版商
  20. Nakajima W, Hicks M, Tanaka N, Krystal G, Harada H. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer. Cell Death Dis. 2014;5:e1052 pubmed 出版商
  21. Sosa Seda I, Mott J, Akazawa Y, Barreyro F, Bronk S, Kaufmann S, et al. Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition. Hepatol Res. 2010;40:701-10 pubmed 出版商